Cefixime trihydrate is the stable oral form of cefixime, a third-generation cephalosporin antibiotic that inhibits bacterial cell-wall synthesis. It is used to treat various respiratory, urinary, and gastrointestinal bacterial infections. It is grouped under the following drug class(es): Beta-lactams. Its therapeutic use is listed as antibiotics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Cefixime hydrate and Suprax. Its PubChem CID is 44467542.
Cefixime trihydrate
| CAS No | 125110-14-7 |
|---|---|
| Molecular Formula | C16H17N5O8S2 |
| Molecular Weight | 471.5 g/mol |
| Synonyms | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cefixime trihydrate is the stable oral form of cefixime, a third-generation cephalosporin antibiotic that inhibits bacterial cell-wall synthesis. It is used to treat various respiratory, urinary, and gastrointestinal bacterial infections.
The listed CAS number is 125110-14-7.
The listed molecular formula is C16H17N5O8S2.
The listed molecular weight is 471.5 g/mol.
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate.
The source lists Cefixime hydrate and Suprax.